Study finds link between malaria parasites developing antimalarial drug resistance
Spread through Anopheles mosquitoes, the disease affected around 249 million people globally in 2022
Read More
Tag: malaria
Unitaid funds over £6m to Liverpool researchers to treat major diseases
The project aims to advance therapeutics for tuberculosis, malaria and hepatitis C in LMICs
Read More
PhaSER Biomedical receives $2.3m drug discovery grant from the Gates Foundation
Every year, tuberculosis, malaria and HIV cause over five million deaths worldwide
Read More
Johns Hopkins study shows potential for chemical vaccine against malaria
Malaria was responsible for over 600,000 worldwide deaths in 2021
Read More
Medicines for Malaria Venture and Novartis move to phase 3 trial
Ganaplacide/lumefantrinein new study as world faces emerging resistance to malaria treatments
Read More
Manus Bio receives additional funding to combat malaria
Fourth award from the Bill & Melinda Gates Foundation will support artemisinin research
Read More
Novartis invests $250m in malaria elimination commitment
The company has renewed its pledge to eliminate neglected tropical diseases and malaria over five years
Read More
BioNTech to develop a mRNA-based malaria vaccine
Clinical trial for first vaccine candidate is planned for the end of 2022
Read More
Modus Therapeutics partners with Imperial College London on malaria drug
Collaboration will research the effects of Modus’ drug sevuparin in patients with severe malaria
Read More
52 cases of malaria reported in Scotland
The figure is an increase of 4% from the 2017 total.
Read More
Malaria cases remain at highest level since 2011
In a bid to tackle the rise, anti-malarial drug Maloff Protect has been made available over-the-counter.
Read More
World Malaria Day – Nathalie Sohier exclusive
In light of World Malaria Day, we spoke to Nathalie Sohier about her experiences, and the challenges that remain with treating malaria.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
